STRIVERDI RESPIMAT

This brand name is authorized in Austria, Brazil, Cyprus, Germany, Estonia, Spain, Finland, France, Hong Kong, Ireland, Lithuania, Malta, Netherlands, Poland, Romania, Singapore, United Kingdom, United States

Active ingredients

The drug STRIVERDI RESPIMAT contains one active pharmaceutical ingredient (API):

1 Olodaterol UNII 65R445W3V9 - OLODATEROL HYDROCHLORIDE

Olodaterol has a high affinity and high selectivity to the human beta2-adrenoceptor. The compound exerts its pharmacological effects by binding and activation of beta2-adrenoceptors after topical administration by inhalation. Activation of these receptors in the airways results in a stimulation of intracellular adenyl cyclase, an enzyme that mediates the synthesis of cyclic-3',5' adenosine monophosphate (cAMP). Elevated levels of cAMP induce bronchodilation by relaxation of airway smooth muscle cells. Read about Olodaterol

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
STRIVERDI RESPIMAT Inhalation solution	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
R03AC19		R Respiratory system → R03 Drugs for obstructive airway diseases → R03A Adrenergics, inhalants → R03AC Selective beta-2-adrenoreceptor agonists
Discover more medicines within R03AC19

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 504514100019602
Country: DE	Bundesinstitut für Arzneimittel und Medizinprodukte	Identifier(s): 13832831, 16023457, 16023463, 16060151, 16060168, 16362975, 16362981
Country: EE	Ravimiamet	Identifier(s): 1583355, 1583366, 1583377, 1583388
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 78253
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 030584
Country: FR	Base de données publique des médicaments	Identifier(s): 64559568
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 246081, 376784
Country: HK	Department of Health Drug Office	Identifier(s): 63776
Country: IE	Health Products Regulatory Authority	Identifier(s): 46893, 46894
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1086464, 1086465, 1086466, 1086467
Country: MT	Medicines Authority	Identifier(s): MA211/00401
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 113166
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100308670
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W60771001, W60771005, W60771006, W60771007
Country: SG	Health Sciences Authority	Identifier(s): 14553P
Country: US	FDA, National Drug Code	Identifier(s): 0597-0192